Feng‐Shu Hsieh

Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation

Man‐Hsin Hung, Yao‐Li Chen, Li‐Ju Chen et al. · Cell Death and Disease · 2019 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15

Biomarkers to monitor drug-induced phospholipidosis

Elizabeth Baronas, Jang‐Hern Lee, Charles J. Alden et al. · Toxicology and Applied Pharmacology · 2006 · 82 citations

Life Sciences, Pharmacology, Toxicology +12

Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response

Chao‐Yuan Huang, Feng‐Shu Hsieh, Cheng‐Yi Wang et al. · European Journal of Cancer · 2018 · 75 citations

Medicine, Oncology, Pharmacology +17

Palbociclib induces activation of <scp>AMPK</scp> and inhibits hepatocellular carcinoma in a <scp>CDK</scp>4/6‐independent manner

Feng‐Shu Hsieh, Yao‐Li Chen, Man‐Hsin Hung et al. · Molecular Oncology · 2017 · 67 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Prediction of adverse perinatal outcome by maternal serum screening for down syndrome in an asian population

Tsuei‐Ju Hsieh, Tai‐Ho Hung, Jyh‐Ping Hsu et al. · Obstetrics and Gynecology · 1997 · 51 citations

Medicine, Maternal Health, Obstetrics +17